Emergency Medicine Doctors in Aurora, CO Accepting Medicare

264 Emergency Medicine doctors found. Showing 181 - 200

Dr. Julie M. Winkle, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Rachel Elizabeth Brady, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1501 S Potomac St, Aurora, CO 80012 Phone: 303-695-2780

Dr. Kimber F Bogush, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-493-7000

Dr. Emilie J. Calvello Hynes, MD, MPH Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, University Of Colorado Hospital, Aurora, CO 80045 Phone: 720-848-0000

Dr. Dawn C Mccartney, DO Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Marianne Christine Wallis, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Dr. Carol S Vanetti, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2550 S Parker Rd, Ste 206, Aurora, CO 80014 Phone: 303-306-7783    Fax: 303-306-7753

Dr. Evan H Schwartz, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2550 S Parker Rd, Ste 206, Aurora, CO 80014 Phone: 303-306-7783    Fax: 303-306-7753

Dr. Paul M Morton, MD Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 275 S Aspen St, 460 Mdg, Aurora, CO 80011 Phone: 720-847-6485

Dr. Jennifer Mary Singleton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Dr. Tamara L Bogush, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Matthew D. Zuckerman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Todd Guth, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Lynne Miller Yancey, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Diana Jo Godfrey, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Dr. Andra Farcas, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12505 E. 16th Ave, Aurora, CO 80045 Phone: 720-848-4000

Dr. Richard S Klasco, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Lisa Jo Floyd, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 S Potomac St, Aurora, CO 80012 Phone: 303-695-2628    Fax: 303-306-7753

Benjamin Honigman, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-6793

Dr. Swami Nathan Rajaram, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1501 S Potomac St, Aurora, CO 80012 Phone: 303-695-2600

News Archive

VINNOVA to provide SEK 3.6 million for Vitrolife's stem-cell research

Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.

Shipment of Fabrazyme commences from Genzyme's FDA-and-EMA-approved Framingham plant

Genzyme, a Sanofi company, today announced that it has begun shipping Fabrazyme (agalsidase beta) produced at its newly approved plant in Framingham, Massachusetts. As previously communicated, patients in the U.S. are now able to return to full dosing in March. In addition, all new patients in the U.S. are eligible to begin Fabrazyme treatment, at full dosing levels.

Researchers discover new gene for susceptibility to Alzheimer's disease

A large-scale international study involving French researchers from the Inserm-Institut Pasteur Lille-Universit- Lille Nord de France "Public health and molecular epidemiology of ageing-related diseases" joint research unit led by Philippe Amouyel, has just discovered a gene for susceptibility to a rare disease that causes susceptibility to a common one, Alzheimer's disease, providing evidence of the heterogeneous aetiology of Alzheimer's disease.

MSD to distribute and market Labopharm's Tradorec XL in the U.K.

Labopharm Inc. today announced its wholly owned subsidiary, Labopharm Europe Limited, has completed a distribution and supply agreement with Merck Sharp & Dohme Limited (MSD), a United Kingdom (U.K.) subsidiary of Merck & Co., Inc., under which MSD will distribute and market Tradorec XL(R) (once-daily tramadol based on Labopharm's proprietary Contramid(R) technology).

Read more Medical News

› Verified 1 days ago

• «
• 4
• 5
• 6
• 7
• 8
• 9
• 10(current)
• 11
• 12
• 13
• 14